Extensive elevation of BNP but not NT-ProBNP in a patient with advanced urothelial carcinoma in absence of cardiac failure and volume overload

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Potential application of fetal epigenetic markers on the non-invasive prenatal detection of chromosomal abnormality
4. Review
5. Epigenetic mechanisms in bone
6. Opinion Papers
7. Circulating fetal cell-free DNA and prenatal molecular diagnostics: are we ready for consensus?
8. Hepcidin levels in chronic hemodialysis patients: a critical evaluation
9. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL
10. General Clinical Chemistry and Laboratory Medicine
11. Effect of biobanking conditions on short-term stability of biomarkers in human serum and plasma
12. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density
13. Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid
14. Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy
15. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays
16. Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: a cohort study based on major surgeries
17. Rapid extraction, identification and quantification of drugs of abuse in hair by immunoassay and ultra-performance liquid chromatography tandem mass spectrometry
18. Validity and reliability of the ¹³C-methionine breath test for the detection of moderate hyperhomocysteinemia in Mexican adults
19. Quantitative detection of target cells using unghosted cells (UGCs) of DxH 800 (Beckman Coulter)
20. Evaluation of different sized blood sampling tubes for thromboelastometry, platelet function, and platelet count
21. Cancer Diagnostics
22. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations
23. Analytical performance of a new one-step quantitative prostate-specific antigen assay, the FREND™ PSA Plus
24. Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis
25. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival
26. Cardiovascular Diseases
27. Red blood cell distribution width predicts survival in patients with Eisenmenger syndrome
28. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients
29. Corrigendum
30. Standardization and analytical goals for glycated hemoglobin measurement
31. Letter to the Editors
32. Do we need to worry about contamination by circulating fetal DNA?
33. Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and Molecular Biology (SIBioC)
34. Aldosterone measurement with LiaisonXL automated system: remarks about reference range
35. Better blood collection tubes for plasma glucose: ready for prime time?
36. Upregulation of cytokines and IL-17 in patients with hereditary angioedema
37. Underestimation of platelet count on magnesium salt-anticoagulated samples
38. Extensive elevation of BNP but not NT-ProBNP in a patient with advanced urothelial carcinoma in absence of cardiac failure and volume overload